Andrew Orth - May 31, 2021 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
Chief Commercial Officer
Signature
/s/ Krish Krishnan, by power of attorney
Stock symbol
KRYS
Transactions as of
May 31, 2021
Transactions value $
$0
Form type
4
Date filed
6/2/2021, 07:19 PM
Previous filing
May 11, 2021
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KRYS Common Stock 100 May 31, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRYS Stock Option (Right to Buy) Award $0 +205K $0.00 205K May 31, 2021 Common Stock 205K $65.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in four equal annual installments beginning on May 3, 2022.